These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 7571477

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prevalence of HBeAg and HBsAg seroconversion in patients with chronic hepatitis B.
    Stránský J, Chlumská A, Zichová M, Helm R, Mankovecký L, König J.
    Sb Lek; 1993; 94(4):317-25. PubMed ID: 7992018
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
    Sodeyama T, Kiyosawa K, Akahane Y, Tanaka E, Wada S, Oike Y, Nakamura M, Yoda H, Imai Y, Gibo Y.
    Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
    [Abstract] [Full Text] [Related]

  • 5. Clinical and pathophysiological aspects of chronic active hepatitis.
    Iwamura K.
    Tokai J Exp Clin Med; 1986 Apr; 11 Suppl():147-57. PubMed ID: 3452239
    [Abstract] [Full Text] [Related]

  • 6. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A, Sekiya C, Yazaki Y, Tominaga Y, Oohara K, Ono M, Sato H, Hasebe C, Namiki M.
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [Abstract] [Full Text] [Related]

  • 7. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
    Jang JW, Lee YC, Kim MS, Lee SY, Bae SH, Choi JY, Yoon SK.
    J Viral Hepat; 2007 Mar; 14(3):169-75. PubMed ID: 17305882
    [Abstract] [Full Text] [Related]

  • 8. [Clinico-prognostic significance of partial seroconversion in chronic viral hepatitis B follow-up. Wartenbert Study (1974-1994), II].
    Ohlen I, Liegl JM, Selmair H.
    Leber Magen Darm; 1995 Dec; 25(6):259-62. PubMed ID: 8577215
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
    Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, Liaw YF.
    Hepatology; 2002 Jun; 35(6):1522-7. PubMed ID: 12029639
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS, Sung JL, Lai MY.
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H, Ayola B, Lok AS.
    Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
    [Abstract] [Full Text] [Related]

  • 14. [A clinicopathological study of seroconversion from HBeAg to anti-HBe in patients with chronic hepatitis B].
    Liu JH, Yan JC, Wang HP.
    Zhonghua Nei Ke Za Zhi; 1988 Oct; 27(10):621-3, 653. PubMed ID: 3229186
    [No Abstract] [Full Text] [Related]

  • 15. [Basic factors affecting the development of chronic hepatitis B virus infection].
    Jezek P, Chalupa P.
    Cas Lek Cesk; 1991 Feb 22; 130(8):227-30. PubMed ID: 2025893
    [Abstract] [Full Text] [Related]

  • 16. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.
    Fattovich G, Rugge M, Brollo L, Pontisso P, Noventa F, Guido M, Alberti A, Realdi G.
    Hepatology; 1986 Feb 22; 6(2):167-72. PubMed ID: 3957228
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.
    Loriot MA, Marcellin P, Talbodec N, Guigonis V, Gigou M, Boyer N, Bezeaud A, Erlinger S, Benhamou JP.
    Hepatology; 1995 Mar 22; 21(3):627-31. PubMed ID: 7875659
    [Abstract] [Full Text] [Related]

  • 19. [Spontaneous seroconversion of HBeAg into anti-HBe in patients with chronic hepatitis B].
    Hadzić N, Vucelić B, Dubravcić D, Juricić M, Stavljenić A.
    Lijec Vjesn; 1988 Mar 22; 110(6-7):181-4. PubMed ID: 3185086
    [No Abstract] [Full Text] [Related]

  • 20. Clinical presentation and natural history of chronic persistent hepatitis. A multicentre retrospective study on 1197 cases.
    Giusti G, Galanti B, Gaeta GB, Sagnelli E, Piccinino F, Ruggiero G.
    Ital J Gastroenterol; 1991 Mar 22; 23(3):111-8. PubMed ID: 1742503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.